Capricor Therapeutics, Inc. (CAPR) revenue

Revenue · fiscal 2024
$22.27M

Capricor Therapeutics, Inc. (CAPR) reported revenue of $22.27M in fiscal 2024 (the year ended December 31, 2024). That is 11.5% lower than the $25.18M of fiscal 2023. Figures as of 18 Nov 2026, 06:39 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2024
$22.27M
Change on fiscal 2023
−11.5%
Growth, 5 years
+85.8% a year
Growth, 10 years
+16.6% a year
Highest on record
$25.18Mfiscal 2023
Lowest on record
$195.50Kfiscal 2012
Fiscal years on record
142011–2024

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Capricor Therapeutics, Inc. revenue, in more detail

Over the five fiscal years to 2024 revenue grew at a compound 85.8% a year; over ten years the rate was 16.6% a year. Across the 14 fiscal years on record (2011–2024), the highest was $25.18M in fiscal 2023 and the lowest $195.50K in fiscal 2012.

History · 14 fiscal years

Revenue by fiscal year

Capricor Therapeutics, Inc. revenue, year by year

Capricor Therapeutics, Inc. (CAPR) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2024$22.27M 11.5% down
2023$25.18M 886.8% up
2022$2.55M 941.8% up
2021$244.90K 21.1% down
2020$310.25K 69.1% down
2019$1.01M 39.9% down
2018$1.67M 37.3% down
2017$2.67M 33.3% down
2016$4.00M 27.5% down
2015$5.52M 15.3% up
2014$4.79M 851.2% up
2013$503.23K 157.4% up
2012$195.50K 85.6% down
2011$1.35M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on CAPR

Capricor Therapeutics, Inc., figure by figure

Capricor Therapeutics, Inc. (CAPR) overview: price, valuation and scorecard

Capricor Therapeutics, Inc. revenue: questions and answers

What is Capricor Therapeutics, Inc.'s revenue?

Capricor Therapeutics, Inc. (CAPR) reported revenue of $22.27M in fiscal 2024 (the year ended December 31, 2024). That is 11.5% lower than the $25.18M of fiscal 2023.

What is the growth rate of Capricor Therapeutics, Inc.'s revenue?

Over the five fiscal years to 2024 revenue grew at a compound 85.8% a year; over ten years the rate was 16.6% a year.

What are the highest and lowest revenue figures on record for Capricor Therapeutics, Inc.?

Across the 14 fiscal years on record (2011–2024), the highest was $25.18M in fiscal 2023 and the lowest $195.50K in fiscal 2012.

How is Capricor Therapeutics, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Capricor Therapeutics, Inc. (CAPR) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/CAPR/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.